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Abstract
Background: Prenatal exposure to infection and/or inflammation is increasingly recognized to play an important
role in neurodevelopmental brain disorders. It has recently been postulated that prenatal immune activation,
especially when occurring during late gestational stages, may also induce pathological brain aging via sustained
effects on systemic and central inflammation. Here, we tested this hypothesis using an established mouse model of
exposure to viral-like immune activation in late pregnancy.
Methods: Pregnant C57BL6/J mice on gestation day 17 were treated with the viral mimetic polyriboinosinic-
polyribocytidilic acid (poly(I:C)) or control vehicle solution. The resulting offspring were first tested using cognitive
and behavioral paradigms known to be sensitive to hippocampal damage, after which they were assigned to
quantitative analyses of inflammatory cytokines, microglia density and morphology, astrocyte density, presynaptic
markers, and neurotrophin expression in the hippocampus throughout aging (1, 5, and 22 months of age).
Results: Maternal poly(I:C) treatment led to a robust increase in inflammatory cytokine levels in late gestation but
did not cause persistent systemic or hippocampal inflammation in the offspring. The late prenatal manipulation also
failed to cause long-term changes in microglia density, morphology, or activation, and did not induce signs of
astrogliosis in pubescent, adult, or aged offspring. Despite the lack of persistent inflammatory or glial anomalies,
offspring of poly(I:C)-exposed mothers showed marked and partly age-dependent deficits in hippocampus-
regulated cognitive functions as well as impaired hippocampal synaptophysin and brain-derived neurotrophic
factor (BDNF) expression.
Conclusions: Late prenatal exposure to viral-like immune activation in mice causes hippocampus-related cognitive
and synaptic deficits in the absence of chronic inflammation across aging. These findings do not support the
hypothesis that this form of prenatal immune activation may induce pathological brain aging via sustained effects
on systemic and central inflammation. We further conclude that poly(I:C)-based prenatal immune activation models
are reliable in their effectiveness to induce (hippocampal) neuropathology across aging, but they appear unsuited
for studying the role of chronic systemic or central inflammation in brain aging.
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Background
Prenatal exposure to infection and/or inflammation is
increasingly recognized to play an important etiological
role in neurodevelopmental brain disorders, including
schizophrenia [1], autism [2], and bipolar disorder [3].
A number of translational rodent models support such
epidemiological associations by demonstrating multiple
behavioral, cognitive, and neuroanatomical alterations
following prenatal exposure to infectious or immune-
activating agents [4–6]. Increasing evidence suggests
that cytokine-associated inflammatory events, together
with downstream pathophysiological effects such as oxida-
tive stress and (temporary) macronutrient and micronu-
trient deficiency, are critical in mediating the adverse
effects of maternal infection on the fetal system [4, 7, 8].
Disruption of normal fetal development [9, 10], together
with subsequent changes in brain maturation [11, 12],
may then confer increased risk of behavioral and cognitive
dysfunctions in later life.
It has become a popular idea that prenatal exposure to
infectious pathogens or inflammatory stimuli may be a
source of persistent inflammation in the offspring [13].
Furthermore, it has recently been postulated that these
chronic inflammatory abnormalities may facilitate or
even drive pathological brain aging in offspring with pre-
natal infectious histories [13]. The basis to support the
hypothesis, however, is controversial [8]: Whereas some
studies using rodent models of prenatal immune challenge
have reported a chronic up-regulation of circulating in-
flammatory factors such as pro-inflammatory cytokines or
increased microglia activation [14–17], other studies using
the same animal models failed to find overt signs of
systemic or central inflammation persisting into adult
life [18–21]. Besides the notable influence of the gen-
etic background [18, 22, 23] and immune stimulus in-
tensity [23–25], the precise timing of prenatal immune
activation is known to critically determine the nature
and/or severity of the short-term fetal inflammatory re-
sponses and long-term neuropathological outcomes in
the adult offspring [26, 27]. Therefore, it is possible that
the gestational timing of immune activation may similarly
influence the long-term inflammatory consequences.
Indeed, it appears that maternal immune challenges in
early gestation do not reliably induce persistent sys-
temic inflammation and microglia activation in the off-
spring, whereas such inflammatory effects have been
noted following prenatal immune activation in late ges-
tation [8, 17]. For example, we have recently observed a
chronic up-regulation of pro-inflammatory cytokines in
mouse offspring exposed to viral-like immune activa-
tion in late [17] but not early gestation [18, 19]. The in-
flammatory effects in the former condition seemed to
be associated with altered hippocampal microglia acti-
vation [17], suggesting that maternal immune activation
in late pregnancy induces sustained effects on inflamma-
tory processes in the offspring’s hippocampal formation.
It needs to be appreciated, however, that some of the
reported inflammatory effects induced by late prenatal
immune activation were based on relatively small sample
sizes and/or qualitative but not quantitative measure-
ments [17]. Reproducing these inflammatory signatures
using larger sample sizes and quantitative measurements
is therefore clearly warranted in order to confirm the re-
liability of effects. A replication and extension of these
initial findings would also be needed to further examine
the hypothesis that late prenatal immune activation
may induce pathological aging in hippocampal struc-
tures via sustained effects on systemic and central in-
flammation [13].
Against these backgrounds, the present study reexa-
mined whether viral-like immune activation in late
gestation may cause persistent systemic and central
inflammation in the offspring throughout aging. We
used a mouse model of viral-like immune activation
that is based on maternal treatment with the viral mi-
metic polyriboinosinic-polyribocytidilic acid (poly(I:C))
on gestation day 17 (GD 17) in attempts to replicate
and extend our initial findings [17]. Using this model,
we first compared offspring of immune-challenged
and control mothers in a spatial recognition memory
test in order to ascertain the negative influence of
late prenatal immune activation on hippocampus-
regulated cognitive functions [28, 29]. We also mea-
sured food-hoarding behavior, which is a species-
typical behavior known to be sensitive to hippocampal
damage [30, 31]. Following behavioral and cognitive
phenotyping, we examined hippocampal microglia density
by quantification of cells immunoreactive for the ionized
calcium-binding adaptor molecule 1 (Iba1). Potential dif-
ferences in microglia activation were assessed through
morphological analyses of Iba1-positive microglia and
cluster of differentiation 68 (CD68) expression [32–34].
We also measured the density of glial fibrillary acidic pro-
tein (GFAP)-positive astrocytes to examine whether late
prenatal immune activation might induce astrogliosis.
Furthermore, we quantified the levels of prototypical
pro- and anti-inflammatory cytokines in the plasma
and hippocampus to test the hypothesis that late pre-
natal immune activation causes chronic systemic and
central inflammation [17]. Finally, we measured hippo-
campal synaptophysin and brain-derived neurotrophic
factor (BDNF) expression to explore whether the antici-
pated behavioral/cognitive and inflammatory effects of
late prenatal immune challenge might be associated
with impaired synaptic integrity and plasticity [35, 36].
All experiments were conducted when the offspring
reached pubescent (1 month of age), adult (5 months of
age), or aged (22 months of age) stages of life so as to
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explore possible age-dependent effects of prenatal im-
mune activation.
Methods
Animals
C57BL6/J mice were used throughout the study. Female
and male breeders were obtained from Charles River
Laboratories (Sulzfeld, Germany) at the age of 10–14 weeks.
Breeding began after 2 weeks of acclimatization to the
animal holding rooms, which were temperature- and
humidity-controlled (21 ± 1 °C, 55 ± 5 %) facilities
under a reversed light–dark cycle (lights off: 8:00 a.m.
to 8:00 p.m.). All animals had ad libitum access to food
(Kliba 3430, Kaiseraugst, Switzerland) and water. All
procedures described in the present study had been
previously approved by the Cantonal Veterinarian's Office
of Zurich. All efforts were made to minimize the number
of animals used and their suffering.
Maternal immune activation in late pregnancy
C57BL6/J female mice were subjected to a timed mating
procedure as described previously [24]. Pregnant dams
on GD 17 were randomly assigned to receiving either a
single injection of poly(I:C) (potassium salt; Sigma-Aldrich,
Buchs, St. Gallen, Switzerland) or vehicle. Poly(I:C) (5 mg/
kg; calculated based on the pure form poly(I:C)) was dis-
solved in sterile pyrogen-free 0.9 % NaCl (vehicle) solution
to yield a final concentration of 1 mg/ml. It was adminis-
tered intravenously (i.v.) into the tail vein under mild phys-
ical constraint. The dose of poly(I:C) was selected based
on our previous dose-response studies [24, 27] and is
identical to the one used in Krstic et al. [17]. All preg-
nant dams were immediately placed to their home
cages after the injections and were left undisturbed
until the first cage change at 1 week after delivery.
An additional cohort of pregnant dams was used to
ascertain the acute increase in maternal plasma cyto-
kines typically seen following poly(I:C) administration
relative to control treatment [26]. This cohort was pre-
pared as described above, except that they were killed
by decapitation in order to collect trunk blood for the
subsequent determination of maternal plasma cytokine
levels (see below).
Allocation and testing of offspring
All offspring were weaned and sexed on postnatal day
(PND) 21. Littermates of the same sex were caged separ-
ately and maintained in groups of four to five animals
per cage as described above. Only male mice were in-
cluded in all experiments to circumvent bias arising
from sexual dimorphism. For each age of testing, the off-
spring stemmed from multiple independent litters (N =
8–10 for each prenatal treatment conditions) to avoid
possible confounds arising from litter effects; and one to
two male offspring per litter were randomly allocated to
the behavioral/cognitive tests, immunohistochemical ex-
aminations, or cytokine measurements at each testing
age (see below).
All experiments were conducted when the offspring
reached pubescent (1 month of age), adult (5 months of
age), or aged (22 months of age) stages of life. Pubescent
and adult stages were defined based on the gradual at-
tainment of sexual maturity and age-specific behavioral
discontinuities from younger to older animals [37]; and
the aged stage was defined based on previous normative
aging studies in mice [38]. A first cohort of pubescent,
adult, and aged offspring were used for the spatial recog-
nition memory test followed by the immunohistochemi-
cal investigations of microglia and astrocytes. A second
cohort of offspring was used for the food-hoarding test
followed by the measurements of plasma and hippocam-
pal cytokines. A resting period of 5 days was imposed
between the behavioral/cognitive tests (spatial recogni-
tion memory or food-hoarding tests) and the subsequent
post-mortem analyses (immunohistochemical investiga-
tions or cytokine measurements) in order to minimize
potential confounds arising from stress induced by be-
havioral/cognitive testing [25]. Finally, a third cohort of
adult and aged offspring were used to confirm some of
the results that were previously obtained in cohorts 1
and 2 using a behaviorally naïve cohort of animals. The
number of offspring included in each treatment group
and age of testing is given in the additional information
(Additional file 1: Table S1) and in the corresponding
figure legends.
Spatial recognition memory in the Y-maze
Spatial recognition memory was assessed using a Y-maze
exploration procedure established and validated before
[39]. This test uses the natural tendency of rodents to
explore novel over familiar spatial environments. The
apparatus was made of transparent Plexiglas and con-
sisted of three identical arms (50 × 9 cm; length × width)
surrounded by 10-cm high transparent Plexiglas walls.
The three arms radiated from a central triangle (8 cm
on each side) and were spaced 120° from each other. A
removable opaque barrier wall was used to block access
to each arm from the central area. The floor of the maze
was covered with sawdust bedding, which was changed
between sample and choice phases. The maze was ele-
vated 90 cm above the floor and was positioned in a
well-lit room enriched with distal spatial cues. A digital
camera was mounted above the Y-maze apparatus. Im-
ages were captured at a rate of 5 Hz and transmitted to
a PC running the EthoVision tracking system (Noldus
Information Technology, The Netherlands), which calcu-
lated the time spent and distance moved in the three
arms and center zone of the Y-maze.
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The short-term spatial recognition test in the Y-maze
consisted of two phases, called the sample and choice
phases. The allocation of arms (start, familiar, and novel
arm) to a specific spatial location was counterbalanced
across the experimental conditions.
Sample phase
The animals were allowed to explore two arms (referred
to as “start arm” and “familiar arm”). Access to the
remaining arm (“novel arm”) was blocked by the opaque
barrier wall. To begin a trial, the animal was introduced
at the end of the start arm and was allowed to freely ex-
plore both the start and the familiar arms for 5 min.
Test timing was initiated once the subject had made an
entry into the central triangular area, as detected by the
EthoVision tracking system. The animal was then re-
moved and kept in a holding cage prior to commence-
ment of the choice phase. The barrier door was removed
and the sawdust flooring changed to avoid olfactory cues.
Choice phase
The animal was introduced to the maze following a re-
tention interval of 1 min. During the choice phase, the
barrier wall was removed so that the animals could
freely explore all arms of the maze for 2 min. The ani-
mal was then removed from the maze and returned to
the home cage. The sawdust flooring was changed in
preparation for the next trial.
On each trial, the time spent in each of the three arms
was recorded. The relative time spent in the novel arm
during the choice phase was calculated by the formula
([time spent in the novel arm]/[time spent in all
arms]) × 100 and used as the index for short-term
spatial recognition memory. In addition, total distance
moved on the entire maze was recorded and analyzed
in order to assess general locomotor activity.
Food hoarding
The apparatus used to assess food hoarding consisted of
modified home cages (40 cm long, 25 cm wide, and
15 cm high) that were kept in a temperature- and
humidity-controlled (21 ± 1 °C, 55 ± 5 %) holding facility
under a reversed light–dark cycle (lights off: 8:00 A.M.
to 8:00 P.M.) as described above. Each home cage con-
sisted of standard sawdust embedding and a Plexiglas
house (Tecniplast) in the form of a triangle (150 mm
wide, 110 mm wide, and 77 mm high). The cages con-
tained stainless steel grid tops, through which drinking
bottles could be inserted to allow ad libitum water ac-
cess throughout the entire testing period. Each cage was
individually connected to a wire mesh tube (32 cm long,
6 cm in diameter). The mesh consisted of 1-cm squares
and was double-rolled with the meshes misaligned to
prevent food pellets dropping through. Each tube was
filled with 100-g food pellets (Kliba 3430, Provimi Kliba,
Switzerland), which were placed at the distal end of the
hoarding tube. The proximal end of the wire mesh tube
was sealed with a removable wooden plug.
To habituate the animals to the modified home cages,
they were placed individually into the cages 12 h before
the food-hoarding test commenced. During this habitu-
ation period time, access to the hoarding tube was pre-
vented with the wooden plug, so that the animals were
food deprived overnight for 12 h (i.e., from 8:00 p.m. to
8:00 a.m.). The overnight food deprivation served to in-
duce a mild state of hunger before the beginning of test-
ing [29, 30]. On the next morning, the wooden bung
was removed just prior to the onset of the dark phase
(lights off at 8:00 a.m.) to allow access to the hoarding
tube. Each animal had free access to the hoarding tube
for a total of 24 h, during which they were left undis-
turbed. After this period, all food pellets that had been
hoarded into each home base box were collected and
weighed. This provided a measure of food-hoarding be-
havior. The weight of total pellets (hoarded and remaining
in the tube) was determined to assess the amount of
food intake during the 24-h test period. The amount
of food eaten was calculated by the formula: total
amount (in grams) of food pellets placed into the
hoarding tube − (food pellets displaced into the home
cage + food pellets remaining in the tube). All mea-
sures were taken and analyzed by an experimenter
who was blind to the experimental conditions.
Immunohistochemistry
The animals of cohort 1 (see Additional file 1: Table S1)
were deeply anesthetized with an overdose of Nembutal
(Abbott Laboratories, North Chicago, IL, USA) and per-
fused transcardially with phosphate-buffered saline (PBS,
pH 7.4), followed by 4 % phosphate-buffered paraformal-
dehyde solution containing 15 % saturated picric acid.
The dissected brains were post-fixed in the same fixative
for 6 h and processed for antigen retrieval involving
overnight incubation in citric acid buffer (pH 4.5) followed
by a 90-s microwave treatment at 480 W. The brains
were then cryoprotected using 30 % sucrose in PBS,
frozen with powdered dry ice, and stored at −80 °C
until further processing.
Perfused brain samples were cut coronally at 30 μm
thickness from frozen blocks with a sliding microtome.
Six serial sections were prepared for each animal and,
after rinsing in PBS, stored at −20 °C in antifreeze solu-
tion (30 % glycerol and 30 % ethylene glycol in PBS at
25 mM and pH 7.4) until further processing. For immu-
nohistochemical staining, the slices were rinsed three
times for 10 min in PBS and blocked in PBS containing
0.3 % Triton X-100 and 10 % normal serum for 1 h at
room temperature. The following primary antibodies
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were used: rabbit anti-Iba1 (Wako, Neuss, Germany; di-
luted 1:2,000), rat anti-CD68 (AbD Serotec, Oxford, UK;
diluted 1:2,000), rabbit anti-GFAP (Dako, Baar, Switzerland;
diluted 1:5,000), and rabbit anti-synaptophysin (Sigma, di-
luted 1:3,000). The primary antibodies were validated be-
fore [25]. They were diluted in PBS containing 0.3 %
Triton X-100 and 2 % normal serum, and the sections were
incubated free-floating overnight at room temperature.
After three washes with PBS (10 min each), the sections
were incubated for 1 h with the biotinylated secondary
antibodies diluted 1:500 in PBS containing 2 % NGS and
0.3 % Triton X-100. Sections were washed again three
times for 10 min in PBS and incubated with Vectastain kit
(Vector Laboratories, Burlingame, CA, USA) diluted in
PBS for 1 h. After three rinses in 0.1 M Tris-HCl, pH 7.4,
the sections were stained with 1.25 % 3,3-diaminobenzi-
dine and 0.08 % H2O2 for 10–15 min, rinsed again four
times in PBS, mounted, dehydrated, and coverslipped with
Eukitt (Kindler, Freiburg, Germany).
Unbiased stereology and Cavalieri estimations
The numbers of Iba1-, CD68-, or GFAP-immunoreactive
cells were determined by unbiased stereological estima-
tions using the optical fractionator method [40]. With
the aid of the image analysis computer software Stereo
Investigator (version 6.50.1; MicroBrightField, Williston,
VT, USA), every section of a one-in-six series was mea-
sured, resulting in an average of six to seven sections per
brain sample. The following sampling parameters were
used: (1) a fixed counting frame with a width of 60 μm
and a length of 60 μm and (2) a sampling grid size of
200 × 150 μm. The counting frames were placed randomly
at the intersections of the grid within the outlined struc-
ture of interest by the software. The cells were counted
following the unbiased sampling rule using the ×40 oil
lens (numerical aperture (NA), 1.3) and included in the
measurement when they came into focus within the op-
tical dissector [41]. The Gundersen coefficient of error
(CE) ranged between 0.08 and 0.12 for each treatment
group and age (see Additional file 2: Table S2).
All immunohistochemical preparations were quantified
in the cornu ammonis 1 to 3 (CA1–CA3) regions of the
hippocampus (Bregma −1.3 to −2.7 mm), thereby includ-
ing stratum oriens, stratum radiatum, and stratum lacuno-
sum moleculare. Preliminary analyses have revealed no
layer-specific effects of prenatal immune activation (data
not shown), so that the data representing the entire CA
region are presented. In addition, the immunohistochemi-
cal preparations were quantified in the stratum moleculare
of the dentate gyrus (DG; Bregma −1.3 to −2.7 mm). All
brain regions and layers were delineated according to the
Mouse Brain in Stereotaxic Coordinates [42]. Contours
were drawn around the gray matter comprising each re-
gion/layer of interest to measure CA and DG volumes
using the Cavalieri estimator probe provided by Stereo In-
vestigator. Cavalieri estimation showed that there were no
volumetric differences in the CA and DG regions between
poly(I:C)-exposed an control offspring (see Additional file
3: Table S3). Iba1, CD68, and GFAP cell counts were
expressed and analyzed as density measures (immunore-
active cells/volumes in cubic millimeters).
Assessment of microglia morphology
Iba1-immunoreactive microglia were visualized under
the ×63 oil lens (numerical aperture (NA), 1.4) using a
Zeiss Axiophot microscope (Carl Zeiss, Jena, Germany).
Various parameters of microglia cell morphology were
assessed according to the methods described before [25].
These were assessed in the CA1 region to be consistent
with Krstic et al. [17]. A counting frame of 100 × 100 μm
was randomly placed into four sections of a one-in-six
series. All microglia cells captured by the counting frame
were included in the morphological analyses, except
when microglial processes were obscured by either blood
vessels, other cells, or damaged tissue. Three to four
microglia cells in every section of a one-in-six series (see
above) were traced using the software Stereo Investiga-
tor (version 6.50.1; MicroBrightField), for which cell
soma area and the number of primary and secondary
processes were estimated, giving a total of 12 to 16 cells
per animal.
Optical densitometry of synaptophysin immunoreactivity
Quantification of synaptophysin immunoreactivity was
achieved by means of optical densitometry using NIH
ImageJ software as described before [43]. In brief, digital
images were acquired at a magnification of ×5.0 using a
digital camera (Axiocam MRc5; Carl Zeiss) mounted on
a Zeiss Axioplan microscope. Exposure times were set
so that pixel brightness was never saturated and kept
constant. Pixel brightness was measured in the respect-
ive areas of one randomly selected brain hemisphere. In
addition, pixel brightness was measured in non-
immunoreactive areas of the corpus callosum (cc) as
background measurements. The background-corrected
relative optical densities were averaged per brain region
and animal. Four to five hippocampal sections were ana-
lyzed for each animal. Synaptophysin immunoreactivity
was measured in the CA and DG regions (Bregma −1.3
to −2.7 mm) as described above.
Quantification of cytokine proteins in plasma and
hippocampal homogenates
Pubescent, adult, and aged offspring of cohort 2 (see
Additional file 1: Table S1) were killed 5 days after com-
pletion of the food-hoarding test (see above). Pregnant
dams on GD 17 were killed 3 h after poly(I:C) or vehicle
treatment to measure the short-term cytokine effects of
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the maternal manipulation [26]. All mice were killed
by decapitation, and trunk blood was collected in
heparinized tubes (Microvette CB 300 LH, Sarstedt,
Nümbrecht, Germany). Plasma was separated by cen-
trifugation (2000×g, 5 min) and stored at −20 °C until
later analyses. The brains of the offspring were ex-
tracted from the skull and placed on an ice-chilled
plate for extraction of both the left and right hippocampi.
The hippocampi were weighed and stored at −80 °C until
further processing.
The hippocampi from both brain hemispheres were
used to prepare hippocampal homogenates for subse-
quent cytokine protein measurements. The frozen hip-
pocampal samples were placed in 300-μl lysis buffer
containing 50 mM Tris-HCl (pH 7.4), 0.6 M NaCl, 0.2 %
Triton X-100, 0.5 % bovine serum albumin, and protease
inhibitors (1 mM benzamidine, 0.1 mM benzethonium
chloride, and 0.1 mM phenylmethylsulfonyl fluoride).
Once placed in the lysis buffer, samples were allowed to
thaw and were then homogenized (TissueTearor; BioS-
pec Products, Bartlesville, OK, USA) for 10 s, sonicated
(Vibra Cell; Sonics & Materials, Newtown, CT, USA) for
20 s at 10 mV, and centrifuged as described before
[25, 26]. The hippocampal supernatants were then ali-
quoted and frozen at –80 °C until the cytokine assays
were performed.
Cytokine proteins in plasma and hippocampal homog-
enates were quantified using a customized Meso-Scale
Discovery (MSD) V-Plex electrochemiluminescence assay
for mice, which allows ultralow detection of multiple cyto-
kines in mouse plasma and supernatants [44]. V-plex plus
96-well plates coated with primary antibodies directed
against interleukin (IL)-1β, IL-4, IL-6, and tumor necrosis
factor (TNF)-α were used and were treated with the corre-
sponding detecting antibodies, which were prelabeled with
SULFO-TAG™ (MSD, Rockville, Maryland, USA). The
plates were read using the MESO SECTOR S 600 (MSD)
imager and analyzed using MSD’s Discovery Workbench
analyzer and software package. All assays were run ac-
cording to the manufacturer’s instructions. The pro-
inflammatory cytokines IL-1β and IL-6 were selected
based on the findings of Krstic et al [17], showing a
chronic elevation of these cytokines in the plasma and
hippocampus of prenatally poly(I:C)-exposed offspring.
TNF-α was selected to cover another prototypical pro-
inflammatory cytokine secreted by classically activated
(M1) microglia, and IL-4 was selected to probe a
prototypical anti-inflammatory cytokine inducing alter-
native (M2) microglia activation [45]. The detection
limits were 0.05 pg/ml for IL-1β, 0.03 pg/ml for IL-4,
0.4 pg/ml for IL-6, and 0.04 pg/ml for TNF-α. To ex-
press hippocampal cytokine levels, the cytokine con-
centrations quantified in the corresponding hippocampal
lysates were normalized to the animals’ hippocampal
weights measured immediately after hippocampal
dissection.
Quantification of cytokine and BDNF mRNA in
hippocampal specimen
The animals from cohort 3 (see Additional file 1: Table
S1) were used to isolate total RNA from hippocampal
samples of the left brain hemisphere (see above). The
hippocampal samples from the right hemispheres were
used to measure synaptophysin protein using Western
blot analysis (see below). Total RNA was isolated by a
single step of guanidinium isothiocyanate/phenol ex-
traction using PureZol RNA isolation reagent (Bio-Rad
Laboratories s.r.l. Italia) according to the manufac-
turer’s instructions and quantified by spectrophotomet-
ric analysis. An aliquot of each sample was treated with
DNase to avoid DNA contamination. RNA was then
analyzed by TaqMan qRT-PCR (CFX384 real-time sys-
tem, Bio-Rad Laboratories) using the iScript one-step
RT-PCR kit for probes (Bio-Rad Laboratories). The
samples were run in 384-well formats in triplicates as
multiplexed reactions with a normalizing internal con-
trol (36B4) using protocols established and validated
before [12, 39]. Probe and primer sequences for cyto-
kine genes were purchased from Applied Biosystems
(IL-1β: Mm00434228_m1; IL-4: Mm00445259_m1; IL-
6: Mm00446190_m1; TNF-α: Mm00443258_m1) and
were validated before [46]. IL-1β, IL-4, IL-6, and TNF-
α were selected to match the quantification of cytokine
proteins (see above). Probe and primer sequences for
total BDNF, BDNF exon IV, and BDNF exon VI were
designed and purchased from Eurofins MWG-Operon.
The probe and primer sequences of the BDNF genes
are given in the additional information (see Additional
file 4: Table S4). Total BDNF was selected to explore
the effects of prenatal immune activation on expression
of the entire BDNF gene. BDNF exon IV was included
to confirm age-dependent impairments in the expres-
sion of this exon [47], and BDNF exon VI was selected
based on its distinct dendritic localization [48]. For all
genes, thermal cycling was initiated with incubation at
50 °C for 10 min (RNA retrotranscription) and then at
95 °C for 5 min (TaqMan polymerase activation). After
this initial step, 39 cycles of PCR were performed. Each
PCR cycle consisted of heating the samples at 95 °C for
10 s to enable the melting process and then for 30 s at
60 °C for the annealing and extension reactions. Rela-
tive target gene expression was calculated according to
the 2(-delta delta C(T)) method [49].
Western blot analysis of synaptophysin protein
Western blot analysis of synaptophysin protein was per-
formed in the total homogenate of hippocampal tissue
extracted from the right brain hemispheres of cohort 3
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offspring (see Additional file 1: Table S1). Hippocampal
samples were sonicated for 10 s at a maximum power of
10–15 % (Bandelin Sonoplus) in a pH 7.4 ice-cold buffer
(containing 0.32 M sucrose, 0.1 mM EGTA, 1 mM
HEPES solution in presence of a complete set of prote-
ase (Roche), and phosphatase (Sigma-Aldrich) inhibi-
tors). Total protein content was measured according to
the Bradford protein assay procedure (Bio-Rad Labora-
tories), using bovine serum albumin as calibration stand-
ard. Equal amounts of protein were run under
reducing conditions on Any Kd Criterion TGX precast
gels (Bio-rad Laboratories) and then electrophoretically
transferred onto nitrocellulose membranes (Bio-Rad
Laboratories). The blots were blocked with 10 % nonfat
dry milk and then incubated overnight at 4 ° C with
the primary antibody (rabbit anti-synaptophysin, Cell
Signaling Technology, #5461; dilution 1:1,000). Mem-
branes were then incubated for 1 h at room temperature
with a peroxidase-conjugated anti-rabbit immunoglobulin
G (IgG; Cell Signaling Technology; dilution 1:5,000), and
immunocomplexes were visualized by chemiluminescence
using the Chemidoc MP imaging system (Bio-Rad Labora-
tories). Results were standardized using β-actin as the
control protein, which was detected by evaluating the
band density at 42 kDa after probing the membranes with
a polyclonal antibody (1:5,000; Sigma-Aldrich) followed by
a 1:10,000 dilution of peroxidase-conjugated anti-mouse
IgG (Sigma-Aldrich). Synaptophysin protein levels were
calculated using an up-to-date Image Lab software
(Bio-Rad Laboratories).
Statistical analyses
All data were analyzed using parametric analysis of vari-
ance (ANOVA), except for the data obtained in the
food-hoarding test, which were analyzed using non-
parametric tests (see below). In the Y-maze spatial recog-
nition test, the relative time spent in the novel arm and
distance moved during the choice phase were analyzed
using 2 × 3 (prenatal treatment × age) ANOVAs. All im-
munohistochemical and cytokine protein measurements
obtained in the offspring were also analyzed using 2 × 3
(prenatal treatment × age) ANOVAs, whereas maternal
plasma cytokine levels were analyzed using independent
Student’s t tests (two-tailed). Fisher’s least significant
(LSD) post hoc tests were used to compare group differ-
ences whenever appropriate. The dependent measures in
the food-hoarding test (i.e., food hoarded and food eaten
during the 24-h test period) were first subjected to loga-
rithmic transformation (base e) to reduce data skewness
[31] and then analyzed using non-parametric Mann–
Whitney U tests. Non-parametric tests were used in the
food-hoarding test in view of the non-normal distribu-
tion of the primary dependent measures (amount of
food hoarded). Correlations between behavioral/
cognitive, synaptic, and inflammatory variables were per-
formed for each testing age using Pearson’s product
moment correlations, followed by first-order partial
correlations partialling for the two prenatal treatment
conditions. At each testing age, the partial correlations
were used to control for the effects of the independent
variable “prenatal treatment.” Statistical significance
was set at p < 0.05. All statistical analyses were per-
formed using the statistical softwares StatView (version
5.0) and SPSS (version 13).
Results
Short-term cytokine effects of maternal immune
activation
First, we verified the effectiveness of maternal poly(I:C)
treatment to induce plasma cytokine levels in late gesta-
tion. As expected [26, 50], we found that the maternal
immune challenge markedly increased maternal plasma
levels of the pro-inflammatory cytokines IL-1β, IL-6, and
TNF-α compared to control vehicle treatment (Fig. 1).
Maternal poly(I:C) exposure also led to a small but
significant increase in the plasma levels of the anti-
inflammatory cytokine IL-4 (Fig. 1). Together, these
findings confirm that the chosen model of viral-like
immune activation in late gestation is capable of indu-
cing robust short-term effects on plasma cytokine
levels in the pregnant dams.
Effects of late prenatal immune activation on
hippocampus-regulated functions
In a next step, we examined the long-term behavioral
and cognitive consequences of late prenatal immune ac-
tivation by assessing hippocampus-dependent functions
in pubescent (1 month old), adult (5 months old), and
aged (22 months old) offspring born to poly(I:C)-ex-
posed or control mothers. Using a spatial recognition
memory test in the Y-maze, we found that pubescent
and adult control mice showed a clear preference to-
wards the novel arm during the choice phase of the test
(Fig. 2a), suggesting that these animals displayed robust
spatial recognition memory. Such memory declined as a
function of normal aging in animals born to control
mothers, so that aged control offspring showed a
marked (~40 %) reduction in the percent time spent in
the novel arm compared with pubescent or adult control
offspring (Fig. 2a). Significant impairments in spatial rec-
ognition memory were also evident in mice born to
poly(I:C)-exposed mothers. Most interestingly, these
poly(I:C)-induced deficits emerged already at pubescent
age and persisted into the aged stage of life (Fig. 2a).
General locomotor activity, which was indexed by the
distance moved during the choice phase of the Y-maze
test, was not affected by prenatal immune activation or
aging (Fig. 2b). The deficits in spatial recognition
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memory emerging in prenatally immune-challenged off-
spring or aged control mice thus represent genuine cog-
nitive effects rather than alterations in exploratory
behavior per se. Together, these findings demonstrate
that late prenatal immune activation causes an early pu-
bescent onset of spatial short-term memory impairment,
which in control offspring emerges as a result of norma-
tive aging.
We further explored whether the prenatal manipula-
tion might cause deficits in species-typical behaviors
known to be dependent on the hippocampus. Therefore,
we assessed the consequences of late prenatal immune
challenge on food hoarding, which can be disrupted by
hippocampal lesions [30]. In agreement with previous
studies in mice [30, 31], the extent to which mice dis-
placed food from a distant food source to their home
cages was found to be variable, even within individual
experimental groups (Fig. 2c). Despite this variability, we
found that aged offspring of immune-challenged mothers
displayed a significant reduction in the amount of food
hoarded compared to aged control offspring (Fig. 2c).
Similar to mice with hippocampal lesions [30, 31], aged
offspring born to immune-challenged mothers hoarded
virtually no food (Fig. 2c). On the other hand,
immune-challenged and control offspring exhibited
comparable amounts of food hoarding when they were
tested at the pubescent or adult ages (Fig. 2c). Hence,
prenatal immune activation induces a long-term nega-
tive impact on food-hoarding behavior that emerges
specifically during aging. Importantly, this impairment
is unlikely to be attributable to possible differences in
general food intake as no group differences were de-
tected in the analysis of total food eaten during the test
period (Fig. 2d).
Long-term effects of late prenatal immune activation on
hippocampal synaptophysin and BDNF expression
The presence of (age-dependent) behavioral and cognitive
deficits in hippocampus-regulated cognitive functions
prompted us to explore whether late prenatal immune ac-
tivation might affect hippocampal synaptic integrity across
aging. To this end, we quantified the hippocampal immu-
noreactivity of synaptophysin, a vesicle-associated protein
that is rapidly recruited to presynaptic terminals in re-
sponse to presynaptic neuronal activity [51]. Consistent
with previous studies in C57BL6 and CD-1 mice [52, 53],
hippocampal synaptophysin immunoreactivity was gener-
ally lower in pubescent offspring compared with adult
or aged offspring (Fig. 3a). Most interestingly, however,
aged offspring born to immune-challenged mothers dis-
played a significant reduction in the relative density of
synaptophysin in the CA and DG regions compared
with aged control offspring (Fig. 3a, b). We confirmed
reduced hippocampal synaptophysin protein expression
in aged poly(I:C) offspring using additional Western
blot analyses, which were conducted in a behaviorally
naïve cohort of aged offspring (Fig. 3c, d). Hence, this
age-dependent reduction in hippocampal synaptophysin
expression is unlikely to be confounded by the previous
testing history of the animals.
Since presynaptic vesicle-associated proteins such as
synaptophysin are downstream targets of BDNF signal-
ing [54, 55], the reduction in hippocampal synaptophysin
displayed by aged poly(I:C) offspring might be linked to
an age-dependent impairment in hippocampal BDNF ex-
pression. Consistent with this hypothesis, we found that
the hippocampal mRNA levels of total BDNF and BDNF
exon VI were selectively reduced in aged but not adult
offspring born to immune-challenged mothers (Fig. 3e).
Fig. 1 Maternal plasma cytokine levels in response to immune activation in late gestation. Pregnant mice on gestation day 17 were treated with
poly(I:C) (POL; 5 mg/kg, i.v.) or vehicle control (CON) solution, and plasma cytokine levels were measured 3 h post-treatment. *P < 0.05, **P < 0.01,
and ***P < 0.001, based on independent Student’s t tests. N = 6 in each group; all values are means ± s.e.m.
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Consistent with previous aging studies in rats [47], hip-
pocampal mRNA levels of BDNF exon IV were generally
reduced in aged relative to adult mice (Fig. 3e). This aging-
associated effect on BDNF exon IV expression emerged in-
dependently of the prenatal manipulation (Fig. 3e).
Long-term effects of late prenatal immune activation on
hippocampal microglia and astrocytes
On the basis of hippocampus-related behavioral/cognitive
and synaptic deficits manifesting in prenatally immune-
challenged offspring, we examined whether they might
display overt microglia and/or astrocyte anomalies in the
hippocampus. Unbiased stereological estimations of Iba1-
positive microglia in the CA and DG showed that late pre-
natal immune activation did not alter the density (number
of immunoreactive cells/mm3) of total microglia in the
hippocampus throughout aging (Fig. 4a, b). The density of
Iba1-positive microglia was generally lower in the CA and
DG of adult offspring as compared to pubescent or aged
offspring. These age-dependent effects, however, similarly
Fig. 2 Hippocampus-related cognitive and behavioral deficits following late prenatal immune activation. a Short-term spatial recognition memory
in pubescent, adult, and aged offspring born to poly(I:C)-exposed (POL) or control (CON) mothers as assessed using the Y-maze test. The bar plots
show the means ± s.e.m. of percentage time spent in the novel arm during the choice phase of the test. ANOVA revealed a main effect of prenatal
treatment (F(1,61) = 14.72, P < 0.001) and its interaction with age (F(2,61) = 4.62, P < 0.05).
+P < 0.001, reflecting the significant difference between aged
CON and pubescent or adult CON offspring; §P < 0.01, reflecting the significant difference between pubescent or aged POL offspring and pubescent or
adult CON offspring; and #P < 0.001, reflecting the significant difference between adult POL offspring and pubescent or adult CON offspring, based on
Fisher’s least significant (LSD) post hoc tests. N(pubescent CON) = 11, N(pubescent POL) = 10, N(adult CON) = 12, N(adult POL) = 10, N(aged CON) = 12,
N(aged POL) = 12. b Total distance moved (means ± s.e.m.) during the choice phase of the Y-maze test. N(pubescent CON) = 11, N(pubescent POL) =
10, N(adult CON) = 12, N(adult POL) = 10, N(aged CON) = 12, N(aged POL) = 12. c Food-hoarding behavior in pubescent, adult, and aged CON and
POL offspring. The box plots represent the amount of food hoarded (g, ln-transformed). *P < 0.05, reflecting the significant reduction in food
hoarding displayed by aged POL offspring relative to aged CON offspring based on non-parametric Mann–Whitney analysis. N = 10 in each
group and age. d The box plots reflect the total amount of food eaten (g, ln-transformed) during the food-hoarding test. N = 10 in each group
and age
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emerged in poly(I:C)-exposed and control offspring
(Fig. 4a, b).
Late prenatal immune activation also failed to induce
signs of microglia activation. We found no group differ-
ences with respect to cell soma area and primary or
secondary branches of Iba1-positive cells, regardless of
whether these microglia morphological parameters were
quantified in pubescent, adult, or aged offspring (Fig. 4a,
c). Microglia cells from aged offspring generally showed
larger cell soma sizes and increased number of second-
ary branches, and these age-dependent effects were simi-
larly present in poly(I:C)-exposed and control offspring
(Fig. 4a, c). Consistent with the lack of morphological
changes in poly(I:C) offspring relative to controls, the
density of cells expressing CD68, which is typically in-
creased in the lysosomes and endosomes of activated
(phagocytic) microglia [32, 33], was not changed by late
prenatal immune activation (Fig. 4a, d). Similar to Iba1-
positive cells, the density of CD68-positive microglia was
generally lower in the CA and DG of adult offspring as
compared to pubescent or aged offspring (Fig. 4a, d).
Finally, we also did not observe any signs of astroglio-
sis in offspring born to poly(I:C)-exposed mothers rela-
tive to controls. Indeed, stereological estimations of
GFAP-positive cells showed that the density of astrocytes
was similar between poly(I:C) and control offspring irre-
spective of their age (Fig. 4d). Taken together, our results
show that offspring exposed to prenatal viral-like im-
mune activation in late pregnancy do not display overt
signs of microglia or astrocyte anomalies across aging.
Long-term effects of prenatal immune activation on
plasma and hippocampal cytokines
Consistent with our findings showing a lack of enduring
effects of late prenatal immune activation on hippo-
campal microglia and astrocytes (Fig. 4), we did not
find any evidence for altered expression of prototypical
pro-inflammatory (IL-1β, IL-6, and TNF-α) and anti-
inflammatory (IL-4) cytokines in the hippocampus of
prenatally immune-challenged offspring. At each test-
ing age, the protein levels of these cytokines were
highly similar between offspring of poly(I:C)-exposed
Fig. 3 Hippocampal synaptic deficits following late prenatal immune activation. a Relative optical density (in arbitrary units (AU)) of synaptophysin
immunoreactivity in the cornu ammonis (CA; including CA1–CA3 sub-regions) and dentate gyrus (DG) of pubescent, adult, and aged offspring born to
poly(I:C)-exposed (POL) and control (CON) mothers. ANOVA revealed a significant main effect of age (CA: F(2,61) = 108.53, P < 0.001; DG: F(2,61) = 78.27, P
< 0.001) and its interaction with prenatal treatment (CA: F(2,61) = 8.27, P < 0.001; DG: F(2,61) = 3.72, P < 0.05).
+P < 0.001, reflecting significantly lower levels
of synaptophysin immunoreactivity in pubescent CON and POL offspring relative to adult or aged CON and POL offspring; #P < 0.001, reflecting the sig-
nificant difference between aged POL and aged CON offspring; §P < 0.01 and §§P < 0.001, reflecting the significant difference between aged POL and
adult CON or POL offspring, based on Fisher’s least significant (LSD) post hoc tests. N(pubescent CON) = 11, N(pubescent POL) = 10, N(adult CON) = 12,
N(adult POL) = 10, N(aged CON) = 12, N(aged POL) = 12. b Representative hippocampal sections of aged CON and POL offspring stained with anti-
synaptophysin antibody. Note the lack of immunoreactivity in the corpus callosum (cc), which served as normalizing background measurement. c
Quantification of hippocampal synaptophysin protein levels in aged CON and POL offspring using Western blot analysis. *P < 0.05 (t(21) = 2.58), based
on independent Student’s t test. N(aged CON) = 13, N(aged POL) = 10. d Representative Western blot samples for synaptophysin protein in the
hippocampus of aged CON and POL offspring. β-actin is shown as loading control for comparison. e Expression of total BDNF, BDNF exon IV,
and BDNF exon VI in the hippocampus of adult and aged CON and POL offspring. The bar plots show normalized mRNA expression levels as
assessed using quantitative RT-PCR. *P < 0.05 and ***P < 0.001, based on post hoc analyses following the presence of a significant interaction between
prenatal treatment and age (total BDNF: F(1,44) = 4.69, P < 0.05; BDNF exon VI: F(1,48) = 4.71, P < 0.05);
+P < 0.001, reflecting the significant difference
between adult and aged CON or POL offspring associated with the main effect of age (F(1,44) = 15.85, P < 0.001). N(adult CON) = 13, N(adult POL) = 12,
N(aged CON) = 13, and N(aged POL) = 10. All values are means ± s.e.m.
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and control mothers (Fig. 5a). The hippocampal levels
of IL-4 were generally lower in aged offspring com-
pared to pubescent or adult offspring, whereas the
levels of TNF-α were highest in the hippocampus of
pubescent offspring irrespective of the prenatal treat-
ment (Fig. 5a). Using an independent cohort of adult
and aged animals, for which we quantified hippocampal
IL-1β, IL-4, IL-6, and TNF-α mRNA by quantitative
RT-PCR, we further confirmed the absence of altered
hippocampal cytokine production in poly(I:C)-exposed
compared with control offspring. Indeed, these add-
itional analyses showed that IL-1β, IL-4, IL-6, and
TNF-α mRNA levels were expressed at relatively low
levels in the hippocampus of adult and aged offspring,
leading to high cycle threshold (Ct) values ranging be-
tween 32 and 37 cycles [49]. A summary of the average
Ct values for the selected cytokine and house-keeping
genes is provided in the additional information (see
Additional file 5: Table S5).
In line with these findings, late prenatal immune acti-
vation did not induce signs of systemic inflammation as
evaluated by the quantification of plasma pro- and anti-
inflammatory cytokines. Regardless of the precise age of
testing, plasma levels of IL-1β, IL-4, IL-6, and TNF-α
were all highly comparable between offspring exposed
to prenatal immune activation and controls (Fig. 5b).
Plasma IL-4 levels were generally increased in aged off-
spring relative to pubescent or adult offspring regard-
less of the prenatal treatment (Fig. 5b). Similar findings
were obtained when plasma cytokines were measured
in an additional cohort of behaviorally naïve offspring
(see Additional file 6: Figure S1).
Fig. 4 Hippocampal microglia and astrocyte parameters following late prenatal immune activation. a The photomicrographs show typical Iba1-,
CD68-, and GFAP-immunoreactivity in the hippocampus at low and high magnification. b Density (immunoreactive cells/volumes in cubic millimeters)
of Iba1-positive microglia in the cornu ammonis (CA; including CA1–CA3 sub-regions) and dentate gyrus (DG) of pubescent, adult, and aged offspring
born to poly(I:C)-exposed (POL) and control (CON) mothers. +P < 0.01 and §P < 0.001, reflecting the significant difference between adult (CON or POL)
offspring and pubescent or aged (CON or POL) offspring, based on Fisher’s least significant (LSD) post hoc tests following the presence of a significant
main effect of age (CA: F(2,61) = 7.56, P < 0.01; DG: F(2,61) = 12.43, P < 0.001). c Cell soma area, number of primary processes, and number of secondary
processes of Iba1-positive hippocampal microglia in pubescent, adult, and aged CON and POL offspring. §P < 0.001, reflecting the significant difference
between aged (CON or POL) offspring and pubescent or adult (CON or POL) offspring, based on Fisher’s least significant (LSD) post hoc tests following
the presence of a significant main effect of age (cell soma area: F(2,61) = 27.64, P < 0.001; secondary processes: F(2,61) = 57.07, P < 0.001). d
Density (immunoreactive cells/volumes in cubic millimeters) of CD68-positive microglia in the CA and DG of pubescent, adult, and aged
CON and POL offspring. +P < 0.01 and §P < 0.001, reflecting the significant difference between adult (CON or POL) offspring and pubescent
or aged (CON or POL) offspring, based on Fisher’s least significant (LSD) post hoc tests following the presence of a significant main effect
of age (CA: F(2,61) = 6.49, P < 0.01; DG: F(2,61) = 22.70, P < 0.001). e Density (immunoreactive cells/volumes in cubic millimeters) of GFAP-positive astrocytes
in the CA and DG of pubescent, adult, and aged CON and POL offspring. N(pubescent CON) = 11, N(pubescent POL) = 10, N(adult CON) = 12, N(adult
POL) = 10, N(aged CON) = 12, and N(aged POL) = 12 for each measurement; all values are means ± s.e.m.
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Correlations between behavioral/cognitive, synaptic, and
inflammatory variables
We also investigated possible correlations between indi-
vidual behavioral/cognitive, synaptic, and inflammatory
variables. The first cohort of offspring was used to ex-
plore possible correlations between short-term spatial
recognition memory and the various glial parameters
(density of Iba1-, CD68-, and GFAP-positive cells as well
as cell soma area, number of primary processes, and
number of secondary processes of Iba1-positive micro-
glia). We also correlated the glial parameters measured
in the first cohort of animals with hippocampal synapto-
physin immunoreactivity. None of these correlations
attained statistical significance using unprotected Pear-
son’s product moment correlations or first-order partial
correlations controlling for the two prenatal treatment
conditions (see Additional file 7: Table S6), suggesting
that spatial recognition memory or synaptophysin ex-
pression in poly(I:C)-exposed and control offspring are
unrelated to the glial parameters of interest.
The second cohort of offspring was used to explore
possible correlations between food hoarding and hippo-
campal or plasma levels of IL-1β, IL-4, IL-6, and TNF-α.
Again, none of these correlations attained statistical sig-
nificance, neither when using unprotected Pearson’s
product moment correlations nor when using first-order
partial correlations that control for the two prenatal
treatment conditions (see Additional file 8: Table S7).
Hence, the performance of poly(I:C) and control offspring
in the food-hoarding test seems unrelated to the levels of
inflammatory markers in the hippocampus or plasma.
Discussion
A recent hypothesis postulated that viral-like immune
activation in late gestation might exacerbate or even
drive pathological aging in hippocampus-related struc-
tures and functions via sustained effects on systemic and
central inflammation [13]. The present study attempted
to reaffirm some of the cornerstone of this hypothesis by
assessing the putative long-term consequences of late
prenatal immune activation on inflammatory changes in
the offspring throughout aging [17]. To this end, we
used the same prenatal immune activation protocol
(i.v. administration of 5 mg/kg poly(I:C) on GD 17 in
C57BL6/J mice) that has previously been shown to
cause a chronic elevation of IL-1β and IL-6 in the
plasma and/or hippocampus of prenatally immune-
challenged offspring [17]. Using larger sample sizes,
however, we failed to replicate the initial findings of
sustained elevations of systemic or hippocampal pro-
inflammatory cytokine secretion [17]. Furthermore, our
study does not support the previous impression of altered
microglia morphology in this model, which suggested that
prenatal exposure to poly(I:C) on GD 17induced
Fig. 5 Cytokine levels in the hippocampus and plasma following late prenatal immune activation. a Cytokine levels in the hippocampus (HPC) of
pubescent, adult, and aged offspring born to poly(I:C)-exposed (POL) and control (CON) mothers. +P < 0.01, reflecting the significant difference
between IL-4 levels in aged (CON or POL) offspring and pubescent or adult (CON or POL) offspring, based on Fisher’s least significant (LSD) post
hoc tests following the presence of a significant main effect of age (F(2,54) = 9.18, P < 0.001).
#P < 0.05, reflecting the significant difference between TNF-
α levels in pubescent (CON or POL) offspring and adult (CON or POL) offspring, based on Fisher’s least significant (LSD) post hoc tests following the
presence of a significant main effect of age (F(2,54) = 3.19, P < 0.05). b Plasma cytokine levels in pubescent, adult, and aged CON and POL offspring.
§P < 0.001, reflecting the significant difference between IL-4 levels in aged (CON or POL) offspring and pubescent or adult (CON or POL) offspring,
based on Fisher’s least significant (LSD) post hoc tests following the presence of a significant main effect of age (F(2,54) = 37.96, P < 0.001). N = 10 in each
group and age for each measurement; all values are means ± s.e.m.
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morphological changes in hippocampal microglia resem-
bling an activated state [17]. Instead, the present data are
in line with other studies showing that prenatal poly(I:C)-
induced immune activation during middle-to-late gesta-
tion in mice does not cause overt microglia abnormalities
and/or increased pro-inflammatory cytokine production
in hippocampal or cortical regions [20, 22]. Despite the
lack of persistent inflammation, however, we found that
late prenatal immune challenge caused significant and
partly age-dependent deficits in hippocampus-related
cognitive functions. Whilst our study is the first to
examine and document the effects of prenatal immune
activation on food hoarding, the deleterious effects of
prenatal poly(I:C) exposure on spatial recognition memory
has been repeatedly described before [39, 56, 57]. Hence,
viral-like prenatal immune activation in mice can robustly
impair (hippocampus-regulated) behavioral and cogni-
tive functions, whereas at the same time, it fails to in-
duce reliable long-term effects on systemic or central
inflammation.
Various factors may explain the discrepant effects on
inflammatory and glial markers described here and be-
fore [17]. Perhaps the most relevant one involves litter
effects, which can produce spurious findings in develop-
mental studies using multiparous species such as mice
[58, 59]. For each testing age, the present study used 8
to 10 independent litters per prenatal treatment group,
from which 1 to 2 animals were randomly selected for
the subsequent investigations of interest. This experi-
mental design allowed us to minimize potential litter ef-
fects because the number of offspring fully or closely
equaled the number of manipulated dams. In contrast to
the present study, our initial investigations of inflamma-
tory factors in this model partly relied on only 4 off-
spring per age [17]. Arguably, these offspring stemmed
from fewer litters per treatment as compared to the
present study, so that the data in our initial report might
have been confounded by litter effects [17].
On the other hand, it is unlikely that possible volumet-
ric changes in the CA and DG regions may have masked
the expected effects of prenatal immune activation on
glial cell densities. Despite the presence of general aging-
related volumetric changes, Cavalieri estimations revealed
no volumetric differences in hippocampal areas between
control and poly(I:C)-exposed offspring. The latter data
are contrary to the recent findings showing reduced hip-
pocampal volumes following prenatal poly(I:C)-induced
immune activation in rats [11]. Further research will be
needed to verify whether these discrepancies may be re-
lated to possible species differences (rats vs. mice) and/or
methodological differences (in-vivo magnet resonance im-
aging vs. ex-vivo Cavalieri estimations).
It could also be argued that possible differences in
stress perception, be it because of prior behavioral/
cognitive testing or differences in housing conditions,
may have contributed to the differential findings be-
tween our previous report [17] and the present study.
Unlike before [17], the present study examined inflam-
matory cytokines and glial marks in offspring that were
previously subjected to behavioral/cognitive testing. One
possible limitation of this approach is that the animals
were exposed to a certain degree of stress during behav-
ioral testing, so that the previous testing history might
have influenced peripheral and central immune func-
tions to some extent. Based on our long-standing expert-
ise with behavioral examination in mice, however, we
deem this possibility rather unlikely for three main rea-
sons. Firstly, the chosen behavioral tests were associated
only with minimal stress for the animals, as they did not
involve any major aversive events such as foot-shock or
long-term behavioral/cognitive training. Secondly, a 5-
day resting period was imposed between the completion
of behavioral testing and collection of brain samples.
This readily minimized the potential confounds arising
from short-term exposure to stress. Thirdly, we did not
reveal any group differences in plasma or hippocampal
cytokine levels when they were measured in an add-
itional cohort of behaviorally naïve poly(I:C) and control
offspring. At the same time, however, we were able to
confirm the significant reduction in hippocampal synap-
tophysin protein using this additional cohort of behav-
iorally naïve offspring.
One clear advance of the chosen within-subject ap-
proach is that the examination of systemic or central in-
flammation took place against the background of clear
behavioral and cognitive phenotypes. This allowed us to
explore possible correlations between the individual be-
havioral/cognitive, synaptic, and inflammatory variables
of interest. The lack of significant correlations further
supports our conclusions that chronic inflammatory
changes are not required to induce behavioral/cognitive
impairments or synaptic deficits following late prenatal
immune activation. Even though cognitive phenotypes
were assessed in our initial investigation using a large
sample size [17], we did not attempt to replicate the
presence of inflammatory abnormalities in these cogni-
tively phenotyped offspring. Hence, it remained elusive
from our earlier study whether any correlations existed
between the inflammatory and cognitive abnormalities.
Here, we found that aging was necessary to unmask
the poly(I:C)-induced deficits in food hoarding, whereas
impairments in spatial recognition memory were present
already in pubescence and persisted into the aged stages
of life. The pubescent onset of such deficits is consistent
with a previous report using the same viral-like immune
activation model and cognitive test procedures [39]. It
should also be noted that aging itself, that is, in offspring
born to control mothers, caused a significant decline in
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spatial recognition memory. This aging-associated effect
is in line with the observation that hippocampus-
regulated cognitive capabilities generally decline during
the process of normative aging [60, 61]. Against this
background, our data show that late prenatal immune
activation causes an early pubescent onset of spatial rec-
ognition deficits, which in control offspring emerges as a
result of aging. These findings support the hypothesis
that late prenatal immune activation could represent an
early-life environmental risk factor for exacerbated cog-
nitive aging, at least with respect to cognitive processes
that are known to critically involve the hippocampal for-
mation. This association, however, does not seem to in-
volve or be dependent on the presence of chronic
systemic or hippocampal inflammation as previously
postulated [17].
In addition to its effects on spatial recognition mem-
ory, aging per se induced a number of other effects on
cytokine levels and microglia parameters. For example,
we found that aged offspring generally showed higher
plasma levels of IL-4, whereas at the same time, they
displayed reduced hippocampal IL-4 contents. The latter
effect is consistent with previous studies showing that
(microglia-driven) central production of IL-4 declines
with increasing age [62, 63]. The concomitant increase
in plasma IL-4 observed in aged animals suggests that
hippocampal and systemic levels of IL-4 are largely un-
related. Peripheral IL-4 is secreted in large amounts by
T helper 2 (Th2) cells, which produce IL-4 in a positive
feedback loop upon initial activation by IL-4 [64]. The
aging-induced increase in plasma IL-4 levels may be re-
lated to the relative shift in Th2 vs. Th1 cell activity:
Whereas the production of Th1-related cytokines such
as interferon (IFN)-γ typically decreases with increasing
age, the production of Th2-related cytokines such as IL-
4 shows the opposite patterns across aging [65]. Even
though we did not evaluate IFN-γ levels, our findings
are in agreement with this relative Th1/Th2 shift by re-
vealing higher plasma IL-4 levels in aged offspring com-
pared to adult or pubescent offspring.
Other remarkable effects associated with aging per se
involved the noticeable increase in microglia cell soma
and the number of secondary processes. Whereas the
former effect is consistent with previous studies report-
ing age-related soma volume increases [66], the latter
may be related to aging-induced changes in stress per-
ception and/or regulation [67, 68]. Since aging is associ-
ated with impairments in the homeostatic control of
stress responses [67], aged individuals typically show a
hyper-secretion of glucocorticoids and other stress hor-
mones [69], which in turn might lead to sub-chronic or
chronic states of stress. A recent study in rats demon-
strated that chronic stress exposure increases microglia
ramification in the prefrontal cortex [70]. This stress-
induced effect was characterized by a selective increase
in the number of secondary processes and was more
pronounced in larger microglia cells but did not involve
any changes in the cells’ inflammatory signatures [70].
These morphological characteristics are remarkably simi-
lar to the present findings showing increased microglia
ramification and cell soma sizes in the hippocampus of
aged mice, which developed in the absence of hippocam-
pal inflammation. Even though speculative at present, the
similarities between our findings and those documented
after chronic stress [70] exposure raise the possibility
that the aging-induced morphological changes in hip-
pocampal microglia may, at least in part, involve stress-
related mechanisms.
Another novel finding of our study is the age-
dependent manifestation of synaptic abnormalities in
prenatally immune-exposed offspring. Even though the
characterization of such neuronal effects is far from
complete, we were able to identify significant deficits in
hippocampal synaptophysin and BDNF expression in
aged offspring born to immune-challenged mothers.
Synaptophysin is one of the most widely used synaptic
markers, which is typically taken to index synaptic integ-
rity and presynaptic density [35, 59]. It is localized in
presynaptic vesicles and is believed to interact with other
synaptic vesicle proteins to regulate vesicle formation
and/or allocation [35, 71–74]. Consistent with a previous
study in rats [75], we did not detect significant changes
in hippocampal synaptophysin expression when the off-
spring were tested during pubescence or adulthood.
Hence, the age-dependent reduction in hippocampal
synaptophysin following late prenatal immune activation
may be taken as a sign of abnormal presynaptic aging in
the hippocampal areas. Interestingly, this age-dependent
effect temporally coincided with impaired hippocampal
expression of total BDNF, highlighting a possible link
between the two pathological entities. In support of
this possibility, BDNF is known to effectively mobilize
synaptophysin-positive vesicles to presynaptic active zones
[55, 76]. Interestingly, poly (I:C)-exposed offspring also
showed an age-dependent reduction in hippocampal
BDNF exon VI expression. The transcript of BDNF exon
VI shows a constitutive dendritic localization [48] and is
involved in activity-dependent dendritic targeting and
translation of BDNF [77]. Our findings thus suggest
that prenatal immune activation leads to an age-
dependent disruption of BDNF signaling at both pre-
and postsynaptic sites.
The precise involvement of these synaptic deficits in
the precipitation of hippocampus-related cognitive defi-
cits remains unclear and warrants further investigation.
On speculative grounds, however, they are likely to
contribute to functional abnormalities in the hippocam-
pus, especially at older ages. For example, the
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disruption of hippocampal synaptic integrity may
change the electrophysiological properties of the hippo-
campus and allied structures such as the prefrontal cor-
tex. Such abnormalities have indeed been noted
previously using prenatal poly(I:C) models in rats [78–82]
and mice [83, 84], but the electrophysiological signatures
of prenatal immune activation in aged offspring remain to
be explored.
Another relevant question is whether our findings can
be generalized to other models of prenatal immune acti-
vation. Another frequently used model of prenatal im-
mune activation is based on exposure to the bacterial
endotoxin lipopolysaccharide (LPS) [4–6]. Peripheral ad-
ministration of LPS to pregnant dams is typically used to
mimic a systemic bacterial-like acute phase response
during pregnancy [14, 85–90], whereas intrauterine in-
jections of LPS, or the bacterial cell-wall component
peptidoglycan, are used to induce intrauterine inflamma-
tion and associated pathological effects such as preterm
birth and fetal brain injury [91–98]. As reviewed in de-
tail elsewhere [4–6, 99], some of the neuronal effects of
prenatal exposure to distinct immunogens are similar in
pubescent and adult offspring [18, 19, 24, 26, 84, 85, 88],
whereas others seem to be immunogen-specific (e.g.,
86, 87, 90). Since the exploration of prenatal immune
activation effects on brain aging is a relatively recent
event, only little information is thus far available that
would allow a straightforward comparison of whether
or not prenatal exposure to distinct immunogens elicits
similar effects on brain functions during aging. Interest-
ingly, however, a few studies using maternal LPS admin-
istration models show that exposure to bacterial-like
immune activation in late pregnancy exacerbates cogni-
tive aging in the offspring, including age-dependent dis-
ruption of species-typical behaviors, without causing
generalized deficits in sensorimotor abilities and loco-
motor activity [100, 101]. These effects are highly similar
to those reported in our study, which was based on a
model of viral-like immune activation in late gestation.
Hence, there is initial evidence supporting the notion that
prenatal exposure to distinct immunogens can elicit simi-
lar effects on brain functions during aging. An extension
of these findings to models of intrauterine inflammation
seems highly warranted in view of the fact that this in-
flammatory condition is a common clinical scenario asso-
ciated with preterm birth affecting a relatively large
proportion of newborns [102].
Conclusions
The present study shows that prenatal exposure to
viral-like immune activation in late gestation induces
hippocampus-related cognitive and synaptic deficits
across aging. These effects were not associated with
overt signs of inflammation or microglia anomalies
persisting into pubescent, adult, or aged stages of life.
Our findings thus challenge the recent hypothesis that
late prenatal immune activation may induce patho-
logical brain aging via sustained effects on systemic and
central inflammation. Instead, the reexamination of this
hypothesis using larger sample sizes and within-subject
designs strongly suggests that chronic inflammatory re-
sponses are not a prerequisite for the disruption of
hippocampus-related brain functions in offspring ex-
posed to late prenatal immune activation. Furthermore,
the inconsistent effects of prenatal immune activation
on microglia functions across aging also question the
hypothesis whether microglia might assume a key role
in causing late-onset synaptic and behavioral/cognitive
deficits following late prenatal immune challenges [13].
Interestingly, a recent study using the same poly(I:C)-
based immune activation model in mice showed that
there were no significant differences in fetal microglial
cell density or activation levels between offspring of
immune-stimulated and control mothers, regardless of
whether the prenatal immune challenge took place in
middle (GD11.5) or late (GD15.5) pregnancy [103]. Our
interpretations are consistent with these findings and
generally question a major involvement of microglia acti-
vation in precipitating short- and long-term brain abnor-
malities following prenatal immune activation. Many of
the structural and functional brain abnormalities identi-
fied in offspring of immune-challenged mothers may
thus rather have an early neurodevelopmental origin
and/or arise as a consequence of altered functional
brain maturation regardless of major microglia anomal-
ies or chronic inflammation.
Additional files
Additional file 1: Table S1. Summary of offspring used in each cohort.
The table summarizes the number of offspring born to poly(I:C)-exposed
(POL) and control (CON) mothers used at each testing age (pubescent
(1 month old), adult (5 month old), and aged (22 month old)) and
specifies the number of litters used to generate the offspring. The table
also summarizes the individual experiments that were performed in
each cohort. All cohorts were prepared using the same maternal
manipulations (treatment with 5 mg/kg poly(I:C) or vehicle (sterile
pyrogen-free 0.9 % NaCl) on gestation day 17) in C57BL6/J mice and
included male offspring only. (DOCX 93 kb)
Additional file 2: Table S2. Summary of the Gundersen coefficient of
error (CE) associated with the stereological analyses in the cornu ammonis
(CA; including CA1–CA3 sub-regions) and dentate gyrus (DG) of pubescent,
adult, and aged offspring born to poly(I:C)-exposed (POL) and control (CON)
mothers. The data represent the CEs obtained in the stereological analyses
of Iba1. Similar CE values were obtained in the stereological analyses of
CD68 and GFAP (data not shown). N(pubescent CON) = 11, N(pubescent
POL) = 10, N(adult CON) = 12, N(adult POL) = 10, N(aged CON) = 12, and
N(aged POL) = 12 for each measurement; all values are group means ± s.e.m.
(DOCX 92 kb)
Additional file 3: Table S3. Volumes of cornu ammonis (CA; including
CA1–CA3 sub-regions) and dentate gyrus (DG) of pubescent, adult, and
aged offspring born to poly(I:C)-exposed (POL) and control (CON) mothers.
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CA and DG volumes were measured using the Cavalieri estimator probe
provided by Stereo Investigator. The data represent the volumes obtained
in the analyses of the Iba1 immunohistochemical series. Similar data were
obtained in the analyses of CD68 and GFAP immunohistochemical series
(data not shown). A 2 × 3 (prenatal treatment × age) ANOVA only yielded a
significant main effect of age (CA: F(2,61) = 31.09, P < 0.001; DG: F(2,61) = 49.78,
P < 0.001). aP < 0.001, reflecting the significant difference between adult
offspring and pubescent or aged offspring and bP < 0.001, reflecting the
significant difference between aged and pubescent offspring, based on
Fisher’s least significant difference (LSD) post hoc tests. N(pubescent
CON) = 11, N(pubescent POL) = 10, N(adult CON) = 12, N(adult POL) =
10, N(aged CON) = 12, and N(aged POL) = 12 for each measurement; all
values are means ± s.e.m. (DOCX 106 kb)
Additional file 4: Table S4. Sequences of forward and reverse primers
used in the real-time PCR analyses of total brain-derived neurotrophic
factor (BDNF), BDNF exon IV, BDNF exon VI, and the house-keeping
gene 36B4. (DOCX 46 kb)
Additional file 5: Table S5. Summary of the average cycle threshold
(Ct) values for the cytokines genes (IL-1β, IL-4, IL-6, and TNF-α) and
house-keeping gene (36B4) measured in the hippocampi of adult and
aged offspring born to poly(I:C)-exposed (POL) and control (CON)
mothers using real-time PCR. N(CON-adult) = 13, N(POL-adult) = 12,
N(CON-aged) = 13, and N(POL-aged) = 10. (DOCX 98 kb)
Additional file 6: Figure S1. Plasma cytokine levels in a behaviorally
naïve cohort of adult and aged offspring exposed to prenatal immune
activation or control treatment. The graphs depict plasma levels (pg/ml)
of IL-1β, IL-6, and TNF-α in adult and aged offspring born to poly(I:C)-
exposed (POL) and control (CON) mothers. +P < 0.05, reflecting the general
increase in IL-1β plasma levels in aged offspring relative to adult offspring,
based on post hoc analysis following the presence of a significant main
effect of age (F(1,44) = 4.99, P < 0.05). N(CON-adult) = 13, N(POL-adult) = 12,
N(CON-aged) = 13, and N(POL-aged) = 10; all values are means ± s.e.m.
(DOCX 352 kb)
Additional file 7: Table S6. Summary of correlations between cognitive,
synaptic, and glia readouts in pubescent, adult, and aged offspring born to
poly(I:C)-exposed (POL) or control (CON) mothers. For each age, first-order
partial correlations controlling for the two prenatal treatment conditions
were carried out using the dependent measures of main interest. Percent
time spent in the novel of arm during the choice phase of the Y-maze
spatial recognition test was taken as the primary cognitive readout, whereas
the number of Iba1+, CD68+, and GFAP+ cells in the cornu amonis (CA;
including CA1–CA3 sub-regions) and dentate gyrus (DG) regions served
as glial readouts. CA and DG synaptophysin (SYN) immunoreactivity (IR)
was taken as the main synaptic measure. (DOCX 115 kb)
Additional file 8: Table S7. Summary of correlations between food
hoarding (g, ln-transformed) and plasma (p) and hippocampal (h) cytokine
levels in pubescent, adult, and aged offspring born to poly(I:C)-exposed
(POL) or control (CON) mothers. For each age, first-order partial correlations
controlling for the two prenatal treatment conditions were carried using the
dependent measures of main interest. (DOCX 71 kb)
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